NZ553274A - Growth hormone releasing hormone enhances the immune response induced by vaccination - Google Patents

Growth hormone releasing hormone enhances the immune response induced by vaccination

Info

Publication number
NZ553274A
NZ553274A NZ553274A NZ55327405A NZ553274A NZ 553274 A NZ553274 A NZ 553274A NZ 553274 A NZ553274 A NZ 553274A NZ 55327405 A NZ55327405 A NZ 55327405A NZ 553274 A NZ553274 A NZ 553274A
Authority
NZ
New Zealand
Prior art keywords
ghrh
subject
nucleic acid
expression construct
tissue
Prior art date
Application number
NZ553274A
Other languages
English (en)
Inventor
Ruxandra Draghia-Akli
Patricia A Brown
Amir S Khan
William C Davis
Original Assignee
VGX Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VGX Pharmaceuticals LLC filed Critical VGX Pharmaceuticals LLC
Publication of NZ553274A publication Critical patent/NZ553274A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ553274A 2004-07-23 2005-07-21 Growth hormone releasing hormone enhances the immune response induced by vaccination NZ553274A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59073904P 2004-07-23 2004-07-23
PCT/US2005/025747 WO2006014737A2 (en) 2004-07-23 2005-07-21 Growth hormone releasing hormone enhances the immune response induced by vaccination

Publications (1)

Publication Number Publication Date
NZ553274A true NZ553274A (en) 2010-02-26

Family

ID=35717476

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ553274A NZ553274A (en) 2004-07-23 2005-07-21 Growth hormone releasing hormone enhances the immune response induced by vaccination

Country Status (10)

Country Link
US (1) US20060025368A1 (enExample)
EP (1) EP1809336B1 (enExample)
JP (1) JP2008507537A (enExample)
CN (1) CN101027081A (enExample)
AT (1) ATE413890T1 (enExample)
AU (1) AU2005269724B2 (enExample)
DE (1) DE602005011041D1 (enExample)
MX (1) MX2007000893A (enExample)
NZ (1) NZ553274A (enExample)
WO (1) WO2006014737A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846720B2 (en) * 2005-01-26 2010-12-07 Vgx Pharmaceuticals, Inc. Optimized high yield synthetic plasmids
JP2011504111A (ja) * 2007-05-21 2011-02-03 サイト パルス サイエンシズ、インコーポレイテッド ポリヌクレオチドワクチンを哺乳類の皮膚に送達するための方法及び装置
WO2010044919A2 (en) * 2008-05-28 2010-04-22 Vgx Pharmaceuticals, Inc. Smallpox dna vaccine and the antigens therein that elicit an immune response
CN108707589B (zh) * 2018-06-07 2021-11-26 西南民族大学 一种牛病毒性腹泻病毒SMU-Z6/1a/SC/2016分离株及其应用
CN116328742B (zh) * 2023-04-27 2024-08-30 大连理工大学 一种核壳型磁性分子印迹聚合物材料、制备方法及应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224316A (en) * 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223019A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228156A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223021A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4226857A (en) * 1979-03-30 1980-10-07 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228158A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
US5134120A (en) * 1984-08-03 1992-07-28 Cornell Research Foundation, Inc. Use of growth hormone to enhance porcine weight gain
US5036045A (en) * 1985-09-12 1991-07-30 The University Of Virginia Alumni Patents Foundation Method for increasing growth hormone secretion
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US4833166A (en) * 1987-05-01 1989-05-23 Grosvenor Clark E Growth hormone releasing hormone complementary peptides
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
USRE33699E (en) * 1987-07-09 1991-09-24 International Minerals & Chemical Corp. Growth hormone-releasing factor analogs
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5023322A (en) * 1988-08-31 1991-06-11 Mta Kutatas-Es Szervezetelemzo Intezete Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5134210A (en) * 1989-07-27 1992-07-28 Edwards Bill R Acrylic resin composition
US5137872A (en) * 1989-09-18 1992-08-11 Pitman-Moore, Inc. Growth hormone-releasing factor analogs
JPH06500311A (ja) * 1990-06-29 1994-01-13 エフ・ホフマン―ラ　ロシュ　アーゲー ヒスチジン置換されたヒト成長ホルモン放出因子類縁体
US5486505A (en) * 1990-07-24 1996-01-23 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
AU662731B2 (en) * 1991-04-09 1995-09-14 F. Hoffmann-La Roche Ag Growth hormone releasing factor analogs
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5439440A (en) * 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5792747A (en) * 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
WO1996032126A1 (en) * 1995-04-14 1996-10-17 The Administrators Of The Tulane Educational Fund Analogs of growth hormone-releasing factor
PT994721E (pt) * 1997-05-01 2007-03-30 Protechtion Unltd Inc Factor de crescimento do tecido nervoso como adjuvante de vacina
BR0001606A (pt) * 1999-04-12 2001-04-24 Pfizer Prod Inc Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimento
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
WO2003047602A1 (en) * 2001-12-07 2003-06-12 Intercell Ag Immunostimulatory oligodeoxynucleotides
CA2469310C (en) * 2001-12-11 2013-01-29 Advisys, Inc. Plasmid mediated supplementation for treating chronically ill subjects
WO2003099341A1 (en) * 2002-05-28 2003-12-04 Advisys, Inc. Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system

Also Published As

Publication number Publication date
US20060025368A1 (en) 2006-02-02
AU2005269724A1 (en) 2006-02-09
WO2006014737A2 (en) 2006-02-09
AU2005269724B2 (en) 2011-03-10
EP1809336B1 (en) 2008-11-12
JP2008507537A (ja) 2008-03-13
ATE413890T1 (de) 2008-11-15
CN101027081A (zh) 2007-08-29
DE602005011041D1 (de) 2008-12-24
EP1809336A2 (en) 2007-07-25
WO2006014737A3 (en) 2006-05-11
MX2007000893A (es) 2007-04-18

Similar Documents

Publication Publication Date Title
US20090292107A1 (en) Composition and method to alter lean body mass and bone properties in a subject
EP1465654B1 (en) Plasmid mediated supplementation for treating chronically ill subjects
AU2002348417A1 (en) A composition and method to alter lean body mass and bone properties in a subject
WO2004067719A2 (en) Growth hormone releasing hormone (ghrh) for use in reducing culling in herd animals
EP1809336B1 (en) Growth hormone releasing hormone enhances the immune response induced by vaccination
US8188056B2 (en) Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation
US8058253B2 (en) Growth hormone releasing hormone treatment to decrease cholesterol levels
CA2563312C (en) Plasmid mediated ghrh supplementation for renal failures
JP2008507537A5 (enExample)
US7517863B2 (en) Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide
US20090005333A1 (en) Reducing culling in herd animals growth hormone releasing hormone (ghrh)
MC et al. GHRH ZUR VERWENDUNG BEI DER BEHANDLUNG VON CHRONISCHER NIERENINSUFFIZIENZ GHRH POUR LE TRAITEMENT DES INSUFFISANCES RENALES CHRONIQUES

Legal Events

Date Code Title Description
PSEA Patent sealed
S35A Application for proceedings under section 35 (restoration of lapsed patents)
LAPS Patent lapsed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 21 DEC 2015 BY SPRUSON + FERGUSON

Effective date: 20130207

S35R Proceedings under section 35 (restoration of lapsed patents): patent restored
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2016 BY COMPUTER PACKAGES INC

Effective date: 20150701

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2017 BY COMPUTER PACKAGES INC

Effective date: 20160701

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2018 BY COMPUTER PACKAGES INC

Effective date: 20170701

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2019 BY COMPUTER PACKAGES INC

Effective date: 20180703

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2020 BY COMPUTER PACKAGES INC

Effective date: 20190702

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2021 BY COMPUTER PACKAGES INC

Effective date: 20200701

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2022 BY CPA GLOBAL

Effective date: 20210617

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2023 BY CPA GLOBAL

Effective date: 20220609

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2024 BY CPA GLOBAL

Effective date: 20230608

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUL 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20240606

EXPY Patent expired